Nikko Asset Management Americas, Inc. Moderna, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 850,035 shares of MRNA stock, worth $33.5 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
850,035
Previous 701,049
21.25%
Holding current value
$33.5 Million
Previous $83.2 Million
31.76%
% of portfolio
0.66%
Previous 0.97%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.67 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.58 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...